Urinary lactate excretion to monitor the efficacy of treatment of type I glycogen storage disease.
The purpose of this study was to investigate the usefulness of urinary lactate measurements to assess the adequacy of dietary treatment in patients with type I glycogen storage disease (GSD-I). We determined the correlation of urine and blood lactate concentrations in 21 GSD-I patients during 24-h admissions to the General Clinical Research Center (GCRC) during which hourly blood samples and aliquots of every void were obtained. In all but 1 patient, we found a good correlation between blood lactate concentrations and urinary lactate excretion. One patient did not excrete lactate in significant amounts despite elevated blood lactate concentrations. In 17 patients, the highest blood lactate concentrations occurred during the night. Markedly elevated nighttime average blood lactate concentrations above 3.5 mmol/l resulted in a urinary lactate concentration above the normal limit of 0.067 mmol/mmol creatinine in the first morning urine specimen. Mildly elevated nighttime blood lactate concentrations (between 2.2 and 3.5 mmol/l) led to urinary lactate concentrations that were either normal or moderately elevated. All patients with normal blood lactate concentrations during the night also had normal first morning urinary lactate concentrations. The degree of urinary lactate excretion in relation to blood lactate concentrations varied by individual. Urinary filter paper specimens, collected at home during the night and in the morning and mailed to the laboratory, were used to monitor the dietary compliance of 5 GSD-I patients at home over a period of 6 to 9 weeks prior to their GCRC admissions. These data suggested variable degrees of dietary control. In conclusion, the urinary lactate concentration is a useful parameter to monitor therapy of GSD-I patients at home. To be interpretable, the baseline urinary lactate concentration in relation to the blood lactate concentration has to be determined.
Division of Genetics, Division of Endocrinology, Department of Medicine, Children's Hospital, 300 Longwood Avenue, Boston, Massachusetts, 02115, USA.
T
T
Hagen
M S
MS
Korson
J I
JI
Wolfsdorf
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005953:Glycogen Storage Disease Type I / Q000097:blood / Q000178:diet therapy* / Q000652:urine*; D006801:Humans; D019344:Lactic Acid / Q000097:blood / Q000652:urine*; D010349:Patient Compliance
D019344:Lactic Acid